Hyo Jeong Yong Selected Research

verbenone

5/2021	SP-8356, a (1S)-(-)-Verbenone Derivative, Inhibits the Growth and Motility of Liver Cancer Cells by Regulating NF-κB and ERK Signaling.
1/2019	SP-8356, a (1S)-(-)-verbenone derivative, exerts in vitro and in vivo anti-breast cancer effects by inhibiting NF-κB signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hyo Jeong Yong Research Topics

Disease

4	Neoplasms (Cancer) 05/2021 - 02/2018
2	Neoplasm Metastasis (Metastasis) 05/2021 - 02/2018
2	Inflammation (Inflammations) 11/2020 - 06/2017
2	Breast Neoplasms (Breast Cancer) 01/2019 - 02/2018
1	Liver Neoplasms (Liver Cancer) 05/2021
1	Ischemia 11/2020
1	Body Weight (Weight, Body) 01/2019
1	Mood Disorders (Mood Disorder) 01/2019
1	Anhedonia 01/2019
1	Triple Negative Breast Neoplasms 02/2018
1	Hypoxia (Hypoxemia) 09/2017
1	Obesity 06/2017
1	Type 2 Diabetes Mellitus (MODY) 01/2016
1	Prediabetic State (Prediabetes) 01/2016

Drug/Important Bio-Agent (IBA)

2	verbenoneIBA 05/2021 - 01/2019
2	SP-8356IBA 05/2021 - 01/2019
1	NF-kappa B (NF-kB)IBA 05/2021
1	Mitogen-Activated Protein KinasesIBA 05/2021
1	CXCR4 Receptors (CXCR4 Receptor)IBA 11/2020
1	Corticotropin-Releasing HormoneIBA 01/2019
1	Antidepressive Agents (Antidepressants)IBA 01/2019
1	CorticosteroneIBA 01/2019
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 01/2019
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2019
1	Galanin Receptors (Galanin Receptor)IBA 01/2019
1	Pharmaceutical PreparationsIBA 02/2018
1	Metalloproteases (Metalloproteinases)IBA 02/2018
1	ErbB Receptors (EGF Receptor)IBA 02/2018
1	Progesterone Receptors (Progesterone Receptor)IBA 02/2018
1	nafamostatIBA 02/2018
1	Transcription Factors (Transcription Factor)IBA 02/2018
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 02/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2017
1	CytokinesIBA 09/2017
1	LipopolysaccharidesIBA 06/2017
1	ImmunosorbentsIBA 01/2016
1	Glucose (Dextrose)FDA LinkGeneric 01/2016
1	EnzymesIBA 01/2016
1	fibroblast growth factor 21IBA 01/2016
1	AdiponectinIBA 01/2016

Therapy/Procedure

2	Therapeutics 01/2019 - 02/2018
1	Drug Therapy (Chemotherapy) 05/2021
1	Intranasal Administration 01/2019